Form 8-K - Current report:
SEC Accession No. 0000950142-25-002208
Filing Date
2025-08-15
Accepted
2025-08-15 16:05:16
Documents
13
Period of Report
2025-08-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh250668029_8k.htm   iXBRL 8-K 28514
2 EXHIBIT 3.1 eh250668029_ex0301.htm EX-3.1 5458
  Complete submission text file 0000950142-25-002208.txt   200804

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE na-20250814.xsd EX-101.SCH 2993
4 XBRL LABEL FILE na-20250814_lab.xml EX-101.LAB 34915
5 XBRL PRESENTATION FILE na-20250814_pre.xml EX-101.PRE 22776
15 EXTRACTED XBRL INSTANCE DOCUMENT eh250668029_8k_htm.xml XML 3631
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
Chrome Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 251224583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)